Home › NDC Lookup › J-codes › J0525
J0525

J0525 – INJECTION, CEFOTETAN DISODIUM, 10 MG · NDC Crosswalk & Billing Units

HCPCS Level II J-code · Medicare Part B drug billing
J-code ● 4 NDCs crosswalked

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

📋 J0525 summary

J0525 is a HCPCS Level II J-code used to bill CEFOTETAN DISODIUM, 10 MG. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.

Brand names associated with J0525: Cefotan, Cefotetan

Code J0525 NDC-Crosswalk 4 RxCUI Atlas Trace the drug concept →

⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.

🗂️ Key billing facts

HCPCS codeJ0525
DescriptorINJECTION, CEFOTETAN DISODIUM, 10 MG
Billing unitNot available in current dataset
Payment limit / unit Not available in current dataset
Mapped NDCs4
Data periodNot available in current dataset
Last updatedSource date not available

💊 About Cefotetan Injection DRUG GUIDE

Cefotetan Injection (Cefotan) treats infections caused by bacteria that are susceptible to it.

These include urinary tract, lower respiratory tract, skin and skin structure, gynecologic, intra-abdominal, and bone and joint infections.Cefotan is also given before certain surgeries to lower the chance of infection afterward.

It does not work against viruses, and it has no activity against Chlamydia trachomatis.

Read the full Cefotetan Injection drug guide →
Clinical overview from our editorial drug guide for Cefotetan Injection. For billing reference, see the sections above.

🧾 Billing & reimbursement HCPCS · CMS

Medicare payment limit / unit
—
Est. ASP / unit
—
Est. after 2% sequester
—
HCPCS dosage
—
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly).

🧮 Dosing & billing-units calculator HCPCS UNITS

One billing unit of J0525 = 1 unit. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.

🔁 NDCs that bill under J0525 CROSSWALKED NDCs

4 NDCs map to J0525. Bill units = how many HCPCS units one package represents.
NDC (11-digit)DrugLabelerPackageStrength Bill units NADAC / unit StatusSource
00121-0976-10 Cefotan Cefotetan 1 g/10mL INJECTION, POWDER, FOR SOLUTION PAI 10 VIAL in 1 TRAY (0121-0976-10) / 10 mL... 1 g/10mL 100 — ● Active PDAC
00121-0977-10 Cefotan Cefotetan 2 g/20mL INJECTION, POWDER, FOR SOLUTION PAI 10 VIAL in 1 TRAY (0121-0977-10) / 20 mL... 2 g/20mL 200 — ● Active PDAC
63323-0385-10 Cefotetan 1 g/10mL INJECTION, POWDER, FOR SOLUTION Fresenius 10 VIAL in 1 CARTON (63323-385-10) / 10 m... 1 g/10mL 100 — ● Active PDAC
63323-0386-20 Cefotetan 2 g/20mL INJECTION, POWDER, FOR SOLUTION Fresenius 10 VIAL in 1 CARTON (63323-386-20) / 20 m... 2 g/20mL 200 — ● Active PDAC
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.

📈 Medicare Part B claims detail CMS PSPS · 2024

Calendar-year 2024 Medicare Part B fee-for-service activity for this HCPCS code, summed across all carriers, localities and specialties (CMS Physician/Supplier Procedure Summary). A “service” is one billed line/unit — not one claim — so counts run higher than claim counts.
Allowed charges
$70.70
Medicare paid
$55.42
Submitted services
200
Submitted charges
$92.00
Source: CMS Physician/Supplier Procedure Summary (PSPS), CY2024 — Medicare Part B carrier + DME fee-for-service claims (excludes Medicare Advantage). Figures are for the whole HCPCS code, which may cover uses beyond this drug. ⚠ CMS hides any figure covering fewer than 11 patients (a privacy rule), so totals — especially denials and low-volume codes — run a little low.

🗺️ Where J0525 is utilized

⏳
The geographic utilization map is building for this code — it aggregates millions of CMS Part B claim lines, then caches the result. Refresh in a moment; if it doesn’t appear, this code may have no reportable Part B utilization.

📊 What bills under J0525

J-codes are billing codes often used for drugs billed under the medical benefit. This connects the billing code to the NDC package records it covers, by ingredient and labeler.

NDC products by ingredient
Cefotetan 2
CEFOTETAN DISODIUM 2
NDC products by labeler
PAI Holdings, LLC dba PAI Pharma 2
Fresenius Kabi USA, LLC 2

🗃️ Data sources & freshness

Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Not available in current dataset
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Not available
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk + DMEPDAC (PDAC)
4 NDCs mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Not available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
No reportable utilization
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.

⚠️ Practical billing caveats

  • A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
  • Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
  • Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
  • Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
  • The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
  • Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.

❓ J0525 billing FAQ

What is HCPCS code J0525?
J0525 is a HCPCS Level II J-code used to bill INJECTION, CEFOTETAN DISODIUM, 10 MG under Medicare Part B and most medical (not pharmacy) benefits.
Which NDCs bill under J0525?
4 NDCs currently map to J0525 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J0525 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.